UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
FORM 3
OMB APROVAL
OMB NUMBER: 3235-0104
Expires: December 31, 2001
Estimated average burden
hours per response........0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public Utility Holding Company Act of 1935
or Section 30(f) of the Investment Company Act of 1940
(Print or Type Responses)
1. Name and Address of Reporting Person*
Morgan Stanley Venture Capital II, Inc.(1)
- -----------------------------------------------------------------------------
(Last) (First) (Middle)
1221 Avenue of the Americas
- -----------------------------------------------------------------------------
(Street)
New York New York 10020
- -----------------------------------------------------------------------------
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/17/99
- -----------------------------------------------------------------------------
3. IRS or Social Security Number of Reporting Person (Voluntary)
- -----------------------------------------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Lionbridge Technologies, Inc. (LIOX)
- -----------------------------------------------------------------------------
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
Director x 10% Owner
--- ---
Officer (give title below) Other (specify below)
--- ---
- ----------------------------------------------------------------------------
6. If Amendment, Date of Original (Month/Day/Year)
- -----------------------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
- ----
x Form filed by More than One Reporting Person
- ----
<PAGE>
Table I -- Non-Derivative Securities Beneficially Owned
<TABLE>
1. Title of Security 2. Amount of Securities 3. Ownership 4. Nature of Indirect
(Instr. 4) Beneficially Owned Form: Direct Beneficial Ownership
(Instr. 4) (D) or Indirect (Instr. 5)
(I)(Instr. 5)
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C>
Common Stock 4,000,002(2) I(3) Through Partnerships
Explanation of Responses:
(1) Please see attached Joint Filer Information.
(2) The number of shares reflects, upon the closing of the Company's initial
public offering, the: (i) automatic conversion of 5,999,990 shares of
Series A Convertible Preferred Stock and 10 shares of Series D Nonvoting
Preferred Stock into 60 shares of Series B Redeemable Preferred Stock and
4,000,002 shares of Series C Convertible Preferred Stock, (ii) automatic
redemption of the Series B Redeemable Preferred Stock for cash and (iii)
automatic conversion of the 4,000,002 shares of Series C Convertible
Preferred Stock into 4,000,002 shares of Common Stock, the result of
which is that Morgan Stanley Venture Capital II, Inc. and its Joint
Filers hold only Common Stock.
(3) Except for Morgan Stanley Venture Capital Fund II Annex, L.P. and Morgan
Stanley Venture Investors Annex, L.P. (collectively, the "Funds"), which
hold the securities directly.
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see
Instruction 5(b)(v).
Page 1 of 3 (Over)
SEC 1473 (3-99)
<PAGE>
FORM 3 (continued)
Table II -- Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<TABLE>
1. Title of Derivative 2. Date Exercisable 3. Title and Amount of 4. Conver- 5. Owner- 6. Nature
Security (Instr. 4) and Expiration Securities Underlying sion or ship of In-
Date (Month/Day/Year) Derivative Security Exercise Form of direct
------------------------- (Instr. 4) Price of Deriv- Bene-
Date Expira- ------------------------- Derivative ative ficial
Exer- tion Title Amount Security Security: Owner-
cisable Date or Direct ship
Number (D) or (Instr.
of Indirect 5)
Shares (I)
(Instr.
5)
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C> <C> <C> <C> <C> <C>
Common Stock Warrants Immed. 3/09/06 Common Stock 255,544 $0.015 I(3) Through
Partnerships
Explanation of Responses:
(3) Except for Morgan Stanley Venture Capital Fund II Annex, L.P. and Morgan
Stanley Venture Investors Annex, L.P. (collectively, the "Funds"), which
hold the securities directly. August 17, 1999
------------------------------- ---------------
**Intentional misstatements or omissions of facts constitute Federal Criminal **Signature of Reporting Person Date
Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. By: Stephanie Holmes, authorized
If space is insufficient, see Instruction 6 for procedure. signatory for Morgan Stanley Dean
Witter & Co. and Assistant Secretary
of Morgan Stanley Venture Capital II,
Inc. the managing general partner of
the Funds.
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB Number.
</TABLE>
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
5(b)(v).
Page 2 of 3
SEC 1473 (3-99)
<PAGE>
Joint Filer Information
Each of the following joint filers has designated Morgan Stanley Venture
Capital II, Inc. ("MSVC II, Inc.") as the "Designated Filer" for purposes of
Item 1 of the attached Form 3:
(1) Morgan Stanley Dean Witter & Co. ("MSDW")
1585 Broadway
New York, New York 10036
(2) Morgan Stanley Venture Partners II, L.P. ("MSVP II, L.P.")
1221 Avenue of the Americas
New York, New York 10020
(3) Morgan Stanley Venture Capital Fund II Annex, L.P. ("MSVCF IIA, L.P.")
1221 Avenue of the Americas
New York, New York 10020
(4) Morgan Stanley Venture Investors Annex, L.P. ("MSVIA, L.P.")
1221 Avenue of the Americas
New York, New York 10020
Issuer & Ticker Symbol: Lionbridge Technologies, Inc. (LIOX)
Date of Event Requiring Statement: 8/17/99
Signature:
--------------------------------------------------------------------
By: Stephanie Holmes, as authorized signatory for
MSDW and Assistant Secretary of MSVC II, Inc., the managing
general partner of MSVP II, L.P., the General Partner of MSVCF
IIA, L.P.
and MSVIA, L.P.
Page 3 of 3
